Japanese Researchers Find CSA-13 May Be Useful for Prevention and Treatment of Dental Caries and Periodontal Disease (Business Wire via Yahoo! Finance)
DENVER----Ceragenix Pharmaceuticals, Inc. , a medical device company focused on infectious disease and dermatology, today announced that in vitro research conducted at the Health Sciences University of Hokkaido found that CSA-13, the Company's lead Ceragenin class of antimicrobial compound, had potent bactericidal activity against all 23 strains of oral bacteria related to dental caries and ...